We observed that knockdown of UCP2 considerably decreased glucose consumption levels (Figure 3A), lactate generation levels (Figure 3B), and the ATP/ADP ratio (Figure 3C) in NSCLC. This evidence concerns the gene UCP2 and non-small cell lung carcinoma.